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Introduction
Chronic inflammation is implicated in the pathogenesis of human cancer, and many lines of evidence point to oxidative modification of DNA as one potential mechanism (1,2).
Phagocytic white blood cells, the cellular hallmark of inflammation, possess an NADPH oxidase that is a well-characterized source of reactive intermediates that damage DNA (3, 4) . The enzyme's initial product is superoxide, which dismutates to hydrogen peroxide (H 2 O 2 ). The oxidizing equivalents in H 2 O 2 are used by myeloperoxidase (5) (6,7), a heme protein expressed by neutrophils, monocytes, and macrophages (8) (9) . At plasma halide concentrations, the major activity of myeloperoxidase is oxidation of chloride to hypochlorous acid (HOCl) (10, 11 Eosinophil peroxidase, an enzyme closely related to myeloperoxidase, produces hypobromous acid (HOBr) (12) . HOCl produced by myeloperoxidase will also generate brominating oxidants in vitro and in vivo by a pathway that might involve bromine chloride (BrCl), HOBr or other halogenating intermediates (13 
Experimental Procedures
Materials. Myeloperoxidase (donor: hydrogen peroxide, oxidoreductase, EC 1.11.1.7)
was isolated from HL60 cells by sequential lectin affinity and size exclusion chromatography (26, 27) . Enzyme concentration (A 430 /A 280 > 0.8) was determined spectrophotometrically (ε 430 = 178 mM -1 cm -1 ;(28)). Chloride-free sodium hypochlorite (NaOCl) was prepared as described (18, 29) . The concentration of NaOCl was determined spectrophotometrically (∈ 292 = 350 M -1 cm chlorouracil by HPLC and GC retention times; its TMS derivative exhibited an identical electron ionization mass spectrum with major fragment masses increased by 6 amu.
which was then back-extracted with 0.2 M ammonium hydroxide and concentrated to dryness under vacuum. The extract was derivatized for electron capture gas chromatography mass spectrometry as described below.
Reverse-phase HPLC. Uracil oxidation products were analyzed and purified for NMR analysis as described (34 Buffer A supplemented with uracil was subjected to the same isolation procedure and analyzed to ensure that ex vivo oxidation or contamination did not account for any observed analyte. 1A ,B). The structure of the uracil oxidation product was investigated by GC/MS (Fig. 1C) . The GC retention times and electron ionization mass spectra of the TMS derivatives of the oxidation product and authentic 5-chlorouracil were essentially identical. The oxidation product exhibited a molecular ion at m/z 290 and a prominent fragment ion at m/z 275 consistent with the ). As anticipated for compounds that lack chlorine, these fragment ions no longer exhibited the prominent (M + 2) isotopic pattern.
Gas chromatography-mass spectrometry (GC/MS
Myeloperoxidase chlorinates uracil at C-5 of the pyrimidine ring. To determine the position of chlorine on the pyrimidine ring of uracil, we used HPLC to isolate the product from the myeloperoxidase reaction mixture and analyzed it with high-resolution 1 H NMR. The spectrum of the product was essentially identical to that of authentic 5-chlorouracil (data not shown), but it was distinct from that of 6-chlorouracil. Significant features included loss of the C-5 proton resonance, a downfield shift in the C-6 proton, and conversion of the C-6 proton resonance from a doublet to a singlet. These findings are consistent with substitution of a chlorine atom at the C-5 position of the pyrimidine ring.
5-Chlorouracil is a specific product of myeloperoxidase.
We used reverse-phase HPLC to characterize uracil chlorination by various peroxidases. 5-Chlorouracil was generated by myeloperoxidase but not by eosinophil peroxidase, lactoperoxidase, or horseradish peroxidase. HOCl generated by myeloperoxidase converts uracil into 5-chlorouracil and that hydroxyl radical, ferrous iron, or glycoxidation reactions are unable to chlorinate uracil under our experimental conditions.
Ascorbate and thiols potently inhibit uracil chlorination by myeloperoxidase. We used HPLC to examine the effects of antioxidants on the yield of 5-chlorouracil produced by the myeloperoxidase system ( Table 2 ). The water-soluble antioxidants ascorbate, N-acetyl cysteine, and glutathione, which react with HOCl to respectively form dehydroascorbate and oxygenated thiols, inhibited uracil chlorination almost completely. Taurine, which reacts with HOCl to produce chloramines, significantly reduced the yield of 5-chlorouracil. Nitrite, a nitric oxide breakdown product, also inhibited uracil chlorination, perhaps by acting as an alternative substrate for myeloperoxidase or by reacting with HOCl to produce nitrosyl chloride and nitrate.
Less effective were trolox, a water-soluble vitamin E analog, and phenol, which would be expected to form p-chlorophenol. Mannitol, frequently used as a hydroxyl radical scavenger, had virtually no effect on 5-chlorouracil production. These observations indicate that water-soluble antioxidants that scavenge HOCl are effective inhibitors of uracil chlorination by myeloperoxidase.
Uracil chlorination by myeloperoxidase has both acidic and neutral pH optima. Uracil chlorination by myeloperoxidase at neutral pH increased with increasing substrate concentration and reaction time ( Fig. 2) and was optimal at plasma concentrations of Cl -(100 mM). The product yield of 5-chlorouracil was ~20% relative to peroxide. The pH dependence for chlorination by myeloperoxidase showed an unusual bimodality, with optima at pH 4 and pH 7
( Fig. 2 ). These observations indicate that myeloperoxidase produces high yields of 5-chlorouracil under both neutral and acidic conditions.
Two distinct reaction pathways chlorinate uracil. To better understand the mechanism for 5-chlorouracil production, we examined the pH dependence of 5-chlorouracil formation by HOCl, the chlorinating intermediate generated by myeloperoxidase (Fig. 3) . Reagent HOCl produced quantitative yields of 5-chlorouracil under both strongly acidic and mildly basic conditions, with the product yield being lowest at pH 5. Because Cl 2 is in equilibrium with HOCl by a reaction requiring Cl -and H + (38), we explored its role in the reaction using chloride-free HOCl. Omitting NaCl ( Fig. 3 ; -NaCl) had little effect on 5-chlorouracil yield when the reaction mixture was > pH 5. In contrast, omission of Cl -markedly diminished product yield when the pH was < 5. Under strongly acidic conditions, chlorination of uracil was independent of Cl -, possibly due to generation of Cl 2 from trace amounts of Cl -contaminant.
At plasma concentrations of Cl -, chlorination of uracil was directly proportional to the concentration of HOCl in the reaction mixture at both pH 4 and pH 8 (Fig. 3) . However, the yield of 5-chlorouracil was increased markedly by Cl -at pH 4 but was independent of Cl -at pH 8. The rate of uracil chlorination was also significantly increased by 100 mM Cl -at pH 4 but not at pH 8 (Fig. 3) . It is noteworthy that the reaction rate was highest at pH 8. In contrast, ring chlorination of deoxycytidine by HOCl is optimal under acidic conditions (18 uracil. Three of these samples also contained 5-bromouracil; levels of this halogenated nucleobase ranged from 3.9 to 59 µmol/mol uracil. When 5-bromouracil was detected, it was more abundant than 5-chlorouracil, suggesting that eosinophil peroxidase contributed to uracil halogenation or that Br -was present at high enough levels to favor bromination by myeloperoxidase (13, 40) .
To determine whether the 5-chlorouracil or 5-bromouracil detected in the samples might have been generated artifactually during workup, we performed three sets of experiments. First, the analytic procedure was applied to samples of plasma or urine from healthy donors. Under these conditions, neither halogenated base was detectable. Second, we quantified the levels of halogenated nucleobases in liver harvested from apparently healthy mice. We, again, failed to detect either 5-chlorouracil or 5-bromouracil (limit of detection, ~ 0.9 nmol/mol uracil)
providing strong evidence that artifactual halogenation of uracil was not taking place during tissue work-up or analysis. Third, uracil labeled with two 13 C atoms and one 15 N atom was added to inflamed tissue. The material was extracted, derivatized, and analyzed by negative ion electron capture GC/MS (Fig. 4A,C 
Discussion
Our results demonstrate that both purified myeloperoxidase and human neutrophils can chlorinate uracil in vitro, and that inflamed human tissue contains both chlorinated and brominated uracil. These findings provide strong evidence that nucleobases are targeted for halogenation during inflammation in human tissue, raising the possibility that oxidants generated by myeloperoxidase and eosinophil peroxidase play key roles in the pathways for DNA damage during inflammation.
Myeloperoxidase is the most likely source of 5-chlorouracil in vivo because the latter is a specific product of the myeloperoxidase system in vitro. In contrast, 5-bromouracil could be generated by either eosinophil peroxidase or myeloperoxidase (13, 34) , both of which preferentially brominate uracil at plasma concentrations of halide (100 mM Cl Previous studies have demonstrated that the artifactual generation of halogenated and nitrated oxidation products is a major problem during the analysis of biological material (42-47).
Indeed, some studies have found that virtually all of the oxidation products detected in tissue were generated artifactually (46,47). This is particularly a problem when acidic conditions are used for sample hydrolysis or derivatization. However, we were unable to detect halogenated nucleobases in human plasma or urine, or in liver harvested from apparently healthy mice.
Moreover, we directly monitored the ex vivo formation of halogenated nucleobases by adding While many studies have focused on direct oxidation of chromosomal DNA as a mechanism for mutagenesis (1,2), we recently showed that myeloperoxidase and eosinophil peroxidase brominate the free nucleobase uracil and the free nucleoside deoxycytidine in vitro at plasma concentrations of chloride and bromide (13, 19, 34) . Mass spectrometry, flow cytometric analysis, and immunohistochemical studies revealed that 5-bromouracil was incorporated into the DNA of dividing mammalian cells exposed to purified 5-bromodeoxycytidine produced by eosinophil peroxidase (19) . Previous studies have also shown that 5-chlorouracil and 5- The complete myeloperoxidase system was as described in the legend to Azide (10 mM) < 10 L-Methionine (6 mM) < 10 Catalase (10 µg/mL) < 10 Superoxide dismutase (10 µg/mL) 186 ± 7
Neutrophils (1 x 10 6 /ml) suspended in buffer B supplemented with 1 mM uracil were activated with 200 nM phorbol myristate acetate and maintained in suspension with intermittent inversion at 37 °C for 60 min. The reaction was terminated by adding 6 mM methionine and centrifuging the cells at 400 x g for 10 min. 5-Chlorouracil was extracted from the supernatant, converted to its pentafluorobenzyl derivative, and analyzed by isotope dilution GC/MS with selected ion monitoring. Values are the means and ranges of two independent experiments, with duplicate determinations in each experiment.
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